Iaso Therapeutics was featured in the Winter 2025 Edition of BioMatters on page 22. The magazine is published by MichBio.

An excerpt from the article reads: With recent acquisitions signaling strong investor interest in the AMR space and the urgent need for new solutions, Iaso’s platform positions the company to deliver multiple candidates across high-value immunization markets – transforming how the industry addresses antimicrobial resistance.